跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM BICARBONATE INJECTION, USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM BICARBONATE INJECTION, USP
Authorized
STANDARD
SODIUM BICARBONATE INJECTION, USP
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
0cfde703f9fb416d
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
0cfde703f9fb416d
Drug Approval Canada Name
SODIUM BICARBONATE INJECTION, USP
Product Name
SODIUM BICARBONATE INJECTION, USP
Status
Cancelled Post Market
Status Date
2025-05-01
Original Market Date
2019-10-04
Din
02486628
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:08.00
Atc Original
B05XA02 SODIUM BICARBONATE
Atc Name
b 05 xa 02
Aig Number
0104153008
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
SODIUM BICARBONATE
42 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
0cfde703f9fb416d
Type
Standard
Back to Health Canada Approvals